Andra språk Pfizer Inc.

Aktier

PFE

US7170811035

Farmaceutiska produkter

Realtidsuppskattning Cboe BZX Andra börsplatser 21.53.28 2026-01-23			5-dagars förändring	Förändring 1 jan.
25,66 ^USD	−0,06 %		−0,02 %	+2,99 %

10.33	Pfizer handlas exklusive utdelning i dag	FW
06.55	USA viktiga bolag - Abbott Laboratories backade 10,0 procent	FW

Andra språk

01-22	Guardant Health, Inc. Receives FDA Approval for Guardant360®? CDx as Companion Diagnostic for BRAFTOVI®? (Encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
01-22	Guardant Health Receives FDA Approval for Colorectal Cancer Diagnostic
01-22	Escalate, De-Escalate, Repeat
01-22	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality
01-21	GSK von seinen Aktionären aufgefordert, seine Neuerfindung zu beschleunigen
01-21	Starkes Quartal macht Johnson & Johnson optimistisch
01-20	European Stocks Close Lower in Tuesday Trading; UK Unemployment Rises to 5.1%
01-20	Global drugmakers rush to boost US presence as tariff threat looms
01-20	Novavax Strikes License Deal With Pfizer for Use of Matrix-M Adjuvant
01-20	Novavax, Inc. Enters into A License and Option Agreement with Pfizer Inc
01-20	Novavax in de lift dankzij licentiedeal met Pfizer
01-20	Novavax Enters Non-Exclusive Licensing Deal With Pfizer
01-20	Novavax Inc enters license agreement with Pfizer - SEC filing
01-20	Novavax signs licensing agreement with Pfizer for vaccine development
01-20	Novavax enters license agreement with Pfizer for vaccine development
01-20	GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments -- Update
01-20	Shionogi & Co Invests $2.13 Billion to Replace Pfizer as ViiV Healthcare Shareholder
01-20	Pfizer to exit ViiV Healthcare in $1.9 billion deal as Shionogi doubles stake
01-20	GSK boosts pipeline with USD2.2 billion purchase of RAPT Therapeutics
01-20	GSK Partner Shionogi to Acquire Pfizer's Stake in HIV-Focused ViiV Healthcare for $2.13 Billion
01-20	UK unemployment flat; GSK buys RAPT Therapeutics
01-20	GSK, Shionogi Finalize Deal for Pfizer's Exit from ViiV Healthcare
01-20	GSK, Pfizer, and Shionogi agree on ViiV Healthcare shareholding changes
01-20	Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits
01-20	GSK makes $2.2 billion swoop for RAPT Therapeutics' food allergy drug

Inga resultat för denna sökning

Alla nyheter Analytikers rekommendationer Viktiga händelser Insiders Transkriptioner Pressmeddelanden Officiella publikationer Andra språk MarketScreener Artiklar MarketScreener Analyser Handelsidéer

Filter

Nyheter

Novo och Pfizer höjer buden i kampen om fetmastartupen Metsera

Den 4 november 2025 kl 19.28